Moreover, we found that IBC tumour-infiltrating B cells also presented high levels of immature signals, which was reflected mainly in the significantly high expression of five molecules, CD22, FCRL1, FCRLA, HVCN1, and SP100, in IBC tumour-infiltrating B cells (Extended Data Fig. S3c). The gene discussed is CD22; the disease is inflammatory breast carcinoma.